Trial intelligence / Profile preview

Celiac Plexus Block for Postoperative Analgesia in Whipple Surgery

NCT05205720Phase 4Completed

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Mar 2022
Primary completion
Nov 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Opioid consumption. Started Mar 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05205720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05205720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call